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Abstract
Nutritional research has shifted recently from alleviating nutrient deficiencies to chronic disease prevention. We
investigated the activity of indicaxanthin, a bioavailable phytochemical of the betalain class from the edible fruit ofOpuntia
ficus-indica (L. Miller) in a rat model of acute inflammation. Rat pleurisy was achieved by injection of 0.2 mL of
l-carrageenin in the pleural cavity, and rats were killed 4, 24, and 48 h later; exudates were collected to analyze
inflammatory parameters, such as nitric oxide (NO), prostaglandin E2 (PGE2), interleukin-1b (IL-1b), and tumor necrosis
factor-a (TNF-a); cells recruited in pleura were analyzed for cyclooxygenase-2 (COX-2), inducible nitric oxide synthase
(iNOS) expression, and nuclear factor k-light-chain-enhancer of activated B cells (NF-kB) activation. Indicaxanthin (0.5, 1, or
2 mmol/kg), given orally before carrageenin, time- and dose-dependently, reduced the exudate volume (up to 70%) and the
number of leukocytes recruited in the pleural cavity (up to 95%) at 24 h. Pretreatment with indicaxanthin at 2 mmol/kg
inhibited the carrageenin-induced release of PGE2 (91.4%), NO (67.7%), IL-1b (53.6%), and TNF-a (71.1%), and caused a
decrease of IL-1b (34.5%), TNF-a (81.6%), iNOS (75.2%), and COX2 (87.7%) mRNA, as well as iNOS (71.9%) and COX-2
(65.9%) protein expression, in the recruited leukocytes. Indicaxanthin inhibited time- and dose- dependently the activation of NF-
kB, a key transcription factor in the whole inflammatory cascade. A pharmacokinetic study with a single 2 mmol/kg oral
administration showed amaximum 0.226 0.02 mmol/L (n = 15) plasma concentration of indicaxanthin, with a half-life of 1.156
0.11 h. When considering the high bioavailability of indicaxanthin in humans, our findings suggest that this dietary pigment has
the potential to improve health and prevent inflammation-based disorders. J. Nutr. 144: 185–192, 2014.
Introduction
Age-related inflammation-based disorders, such as cancer and
cardiovascular disease, are widely acknowledged to have a lower
incidence among populations whose dietary habits include a
large proportion of vegetal food, thus providing various non-
nutrient secondary metabolites (phytochemicals) with purported
beneficial activities (1,2). Thus, despite the wealth of published
papers, the interest in investigating how these food components
may contribute to preventing and/or delaying the development
of such chronic processes is far from waning.
Inflammation is an adaptative response triggered by noxious
stimuli and conditions, such as infection and tissue injury. At a very
basic level, it involves recruitment of blood components, plasma, and
leukocytes, mainly neutrophils [polymorphonuclear cells (PMNs)],5
to the site of infection or injury. This process is coordinated by
a large range of biochemical mediators and results in the inflam-
matory exudate (3). The acute phase of an inflammatory response
successfully ends up in the elimination of the insult, followed by a
resolution phase, mainly mediated by tissue-resident and recruited
macrophages (MPs).
Reactive oxygen and nitrogen species are now acknowledged
to exert a key role in maintaining normal cellular and tissue
physiology but may start signaling pathways involved in the
development of a wide range of inflammation-based degener-
ative pathologies, including cardiovascular and neurodegen-
erative diseases, cancer, and aging itself (4–8). Reactive oxygen
and nitrogen species play a crucial role during the acute phase
of the inflammatory response because they are 1) released from
PMNs and MPs to eliminate the pathogen at the site of inflamma-
tion, 2) involved in the synthesis of proinflammatory mediators,
such as PGs, NO, and peroxynitrite, through both enzymatic and
nonenzymatic free radical-catalyzed reactions, and 3) essential in
the redox-dependent cell signaling of inflammatory cells (9). In this
context, numerous phytochemicals with peculiar reducing proper-
ties that may effectively downregulate the inflammatory response
have recently been the object of research. First considered ‘‘health
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promoting’’ by virtue of their radical-scavenging activity and/or
direct antioxidant effects on cellular biomolecules, such com-
pounds are now believed capable of interfering with cell signal
transduction by intercepting reactive species at the level of
critical signaling pathways. In addition, interaction of these
molecules with signaling enzymes, receptors, and transcrip-
tion factors has emerged recently (10).
Indicaxanthin [(2S)-2,3-dihydro-4-[2-[(2S)-2a-carboxypyrrolidin-
1-yl]ethenyl]pyridine-2a,6-dicarboxylic acid], a phytochemical with
the chemical structure of betalamic acid, is a dietary pigment
from cactus pear fruit (Opuntia ficus-indica, L. Miller). A
number of recent in vitro studies showed that indicaxanthin is a
reducing and amphipathic molecule capable of penetrating cells
and membranes and counteracting oxidative damage (11–18). In
addition, it has been shown to act as a signaling molecule, being
able to modulate specific redox-dependent pathways in cultured
endothelial cells, thus protecting them from dysfunction (19).
Remarkably, indicaxanthin is highly bioavailable in humans (20)
and does not appear to be metabolized either during digestion
or in the liver (21). Investigation from our group provided
evidence that the ingestion of a dietary-consistent amount
of cactus pear fruit pulp (4 fruits, containing 28 mg of
indicaxanthin) generates, in humans, a plasma concentration
of 7 mmol/L (20), quite a high amount compared with most of
the dietary polyphenol phytochemicals, such as flavonoids
(22,23). In this study, we investigated the activity of indicax-
anthin, orally given to rats at doses consistent with a reasonable
dietary intake, in a model of acute inflammatory condition, i.e.,
carrageenin-induced rat pleurisy. This is widely accepted as a
robust pharmacologic model of inflammatory disease, used to
ascertain the anti-inflammatory potential of drugs (24). A
number of molecular markers of inflammation have been
measured to shed light on pathways and mechanistic aspects
associated with the modulatory activity of indicaxanthin.
Materials and Methods
Reagents. l-Carrageenin (1% wt:v) was dissolved in sterile PBS. Unless
otherwise specified, all the other reagents were from Sigma-Aldrich.
Extraction and purification of indicaxanthin from cactus pear
fruits. Indicaxanthin was isolated from cactus pear (O. ficus-indica)
fruits (yellow cultivar). Briefly, the phytochemical was separated from a
methanol extract of the pulp by liquid chromatography on Sephadex
G-25 as reported previously (11). Fractions containing the pigment were
submitted to cryodesiccation, purified according to Stintzing et al. (25)
and suspended in PBS for the experiments.
Animals. Male Wistar rats (Harlan) weighing 175–200 g were used in
all experiments. Rats were fed and had access to water ad libitum. The
light cycle was automatically controlled (on at 0700, off at 1900), and
the room temperature was thermostatically regulated to 22 6 1C.
Before the experiments, rats were housed and acclimatized under these
conditions for 3–4 d. Animal care was in accordance with Italian and
European regulations on the protection of rats used for experimental
and other scientific purposes.
Induction of pleurisy and indicaxanthin treatment. Induction of
pleurisy was as described previously (26). Briefly, rats were slightly
anesthetized, and 0.2 mL of 1% l-carrageenin suspended in sterile saline
solution was injected into the right pleural cavity (control). Rats were
killed 4, 24, and 48 h later in an atmosphere of CO2. The exudate was
harvested by washing each pleural cavity with 2 mL of sterile saline
containing 5 U/mL heparin. Any exudate with blood contamination was
discarded. Each sample was centrifuged at 800 3 g for 10 min, and the
cell pellet was resuspended in saline. Total cell count was estimated after
trypan blue staining using a Burker counting chamber, whereas differ-
ential cell count was determined in smears by May-Grunwald staining.
In parallel, groups of rats received indicaxanthin (0.5, 1, or 2 mmol/kg)
by oral gavage 30 min before carrageenin injection and every 8 h
thereafter, up to 40 h, with control rats receiving saline alone. Rats were
killed at 4, 24, and 48 h after carrageenin injection, and pleural exudates
were collected and processed as described above. In some experiments,
rats received a single oral administration of anti-inflammatory drug
(3 mg/kg indometacin), 30 min before carrageenin injection (26). Pharma-
cokinetics of indicaxanthin were followed by measuring plasma concen-
tration and urinary excretion of the molecule, after a single administration
of 2 mmol/kg. Each experiment was performed three times with groups of
10 rats, with the exception of the pharmacokinetic measurements (five
rats). Data from separate experiments were pooled.
Preparation of cell extracts. The inflammatory cell pellets were
washed twice in PBS (ICN Biomedicals) and centrifuged at 800 3 g for
5 min at 4C.Whole-cell and nuclear extracts were prepared as described
previously (26), aliquoted, and stored at 280C. Protein concentration
was determined by the Bio-Rad protein assay kit.
RT-PCR. Pleural cells were collected under sterile conditions, and total
RNA was isolated using TRIzol Reagent (Invitrogen). Levels of
interleukin-1b (IL-1b), tumor necrosis factor-a (TNF-a), inducible
NO synthase (iNOS), and cyclooxygenase-2 (COX2) mRNA were
evaluated by PCR amplification of reverse-transcribed mRNA as de-
scribed previously (27). Parallel amplification of the rat housekeeping gene
b-actin was performed as internal control. The sequences of the PCR
primers were as follows: for TNF-a, 5#-GTTCTATGGCCCAGACCC-
TCACA-3# (sense) and 5#-TACCAGGGTTTGAGCTCAGC-3# (anti-
sense); for IL-1b, 5#-GACCTGTTCTTTGAGGCTGAC-3# (sense) and
5#-TCCATCTTCTTCTTTGGGTATTGTT-3# (antisense); for iNOS,
5#-GTGTTCCACCAGGAGATGTTG-3# (sense) and 5#-CTCCTGCCCA-
CTGAGTTCGTC-3# (antisense); for COX2, 5#-TGTATGCTACCATC-
TGGCTTCGG-3# (sense) and 5#-GTTTGGAACAGTCGCTCGTCATC-3#
(antisense); and for b-actin, 5#-ATGAAGATCCTGACCGAGGCGT-3#
(sense) and 5#-AACGCAGCTCAGTAACAGTCCG-3# (antisense). The
PCR products were run on a 2% agarose gel and visualized by ethidium
bromide staining.
Western blotting. Cell lysates were prepared as described previously
(28), collected, and stored at 220C until tested. Protein concentration
was determined by Bradford assay according to the instructions of the
manufacturer (Bio-Rad). Immunoblotting analysis of cyclooxygenase-2
(COX-2), iNOS, and b-actin proteins was performed as described
previously (28) with polyclonal antibodies against COX-2, iNOS, or
b-actin (Santa Cruz Biotechnology).
Electrophoretic mobility-shift assay. NF-kB/DNA binding activity
was evaluated by electrophoretic mobility-shift assay in nuclear extracts
as described previously (29). Briefly, 10 mg of protein from each sample
was incubated for 20 min with 32P-labeled, double-stranded NF-kB
consensus binding-site oligonucleotides in 20 mL of binding reaction
buffer. The specificity of the DNA/protein binding was determined by
competition reaction in which a 50-fold molar excess of unlabeled wild-
type, mutant, or AP-1 oligonucleotide was added to the binding reaction
10 min before addition of the radiolabeled probe. In supershift assay,
antibodies reactive to p50, p65, or p50 + p65 proteins were added to the
reaction mixture 30 min before the radiolabeled NF-kB probe. Nuclear
protein–oligonucleotide complexes were analyzed by gel electrophoresis.
Gels were dried and autoradiographed with intensifying screen at280C
for 24 h. Quantitative evaluation of NF-kB/DNA complex formation
was determined by densitometric analysis performed with a GS-700
imaging densitometer (Bio-Rad) and a data computer program (Molec-
ular Analyst; IBM).
PGE2, TNF-a, and IL-1b determination. Levels of PGE2 in the pleural
exudates were measured using a 96-well-based enzyme immunoassay kit
from Cayman Chemicals (Inalco). The proinflammatory cytokines
TNF-a and IL-1b were evaluated using an ELISA kit from eBioscience.
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Determination of oxidation products from nitrite. The amount of
oxidation products from nitrite (NOx) in the inflammatory exudate was
measured after reducing NO3
2 to NO2
2 by acid-washed cadmiun
powder, NO2
2 (30), followed by Griess reaction and spectrophotometric
measurement of NO2
2 (31).
Data handling and statistical analyses.Data are expressed asmeans6
SEMs. Comparisons were made using 1-factor ANOVA, followed by a
Bonferroni test. Time-course comparisons, including time, dose, and
dose 3 time in the model, were tested by 2-factor ANOVA. Differences
between doses at each time level were assessed by a Bonferroni test
(Instat-3 statistical software; GraphPad Software). Comparisons be-
tween effectiveness of indicaxanthin and indomethacin were made by
Student’s t test.
Results
Indicaxanthin counteracts the acute phase of carrageenin-
induced rat pleurisy. The pleural cavity of untreated rats
comparable with those used in this work contains no exudate
and physiologic amounts of leukocytes, predominantly mon-
onuclear (>95%) (32). Injection of 0.2 mL of l-carrageenin
into the pleural cavity of rats (control) produced a clear time-
dependent inflammatory response, evident as an increase of both
the exudate volume and the number of leukocytes migrated into
the pleural cavity. In line with our previously reported data (32),
an increase of these parameters was observed at 4 h, whereas the
acute phase of inflammation peaked at 24 h. The inflammatory
response was shut down at 48 h (Fig. 1A, B). Differential cell count
of leukocytes migrated into the pleural cavity showed that PMNs
dominated the early phase (4 h) of the reaction [91% of PMNs
and 9% of monocytes (MCs)] and were replaced by MCs (29%
of PMNs and 71% of MCs) at 48 h (data not shown).
With respect to control rats, oral administration of indicax-
anthin (2 mmol/kg) 30 min before carrageenin injection and then
for 48 h, at 8 h time intervals, significantly decreased the
inflammatory response at all the time points considered (4, 24,
and 48 h), with inhibition of both the exudate volume and the
total leukocyte number. The inhibitory effect at the peak of
the inflammatory response accounted for >67% and 90% for the
exudate volume and leukocyte number, respectively, and appeared
greater than the inhibitory effects observed at 4 and 48 h (Fig. 1A,
B). Carrageenin-treated rats were administered 0.5–2.0 mmol/kg
indicaxanthin (Fig. 2). With respect to control, both the exudate
volume (Fig. 2A) and the pleural leukocyte number (Fig. 2B)
decreased significantly at 0.5 mmol/kg, with the maximum effect
at 1 mmol/kg (70% and 95% inhibition of the exudate volume
and pleural cell number, respectively). An additional decrease
at 2.0 mmol/kg was not significant. In parallel experiments,
carrageenin-treated rats were given indometacin as a reference
anti-inflammatory drug (26), and the effect was compared
with rats administered 1 mmol/kg indicaxanthin. Indicaxanthin
exhibited the same effectiveness as indometacin at reducing the
exudate volume (n = 30; P = 0.25, Students t test) and was even
more effective at inhibiting the cell recruitment into the pleural
cavity (n = 30; P < 0.0001, Students t test).
FIGURE 1 Effect of indicaxanthin on the time course of exudate
formation (A) and leukocyte infiltration (B) in carrageenin-induced rat
pleurisy. Values are means 6 SEMs, n = 30 (10 rats in 3 separate
experiments). Dose differences at each time level were assessed by
a Bonferroni test. Asterisks indicate that means at a time differ:
*P = 0.0169; ***P , 0.0001; NS indicates P . 0.05. Carr, carrageenin.
FIGURE 2 Exudate volume (A) and leukocyte infiltration (B) at 24 h
in carrageenin-treated rats administered 0–2 mmol/kg indicaxanthin.
Values are means6 SEMs, n = 30 (10 rats in 3 separate experiments).
Labeled means without a common letter differ: P , 0.05.
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Indicaxanthin inhibits the release of proinflammatory
mediators during carrageenin-induced rat pleurisy. The
release into the pleural cavity of a panel of proinflammatory
soluble mediators supporting the acute phase of the inflamma-
tory response (i.e., PGE2, NOx, IL-1b, and TNF-a) was then
evaluated in either the absence or presence of indicaxanthin
supplementation. The injection of 0.2 mL of l-carrageenin
into the pleural cavity of rats caused a release of PGE2, NOx,
IL-1b, and TNF-a at 24 h. Inflammatory mediators are not
detectable in rats before injection (32). Oral administration
of indicaxanthin at 0.5, 1, and 2 mmol/kg dose dependently
decreased the release of all mediators (Fig. 3).
Indicaxanthin inhibits the expression of proinflammatory
genes in carrageenin-induced rat pleurisy. Proinflammatory
genes are not expressed in rats before carrageenin injection (32).
The level of IL-1b,TNF-a, iNOS, andCOX2mRNA at 4 h (Fig.
4A–E) and iNOS and COX-2 protein expression at 24 h (Fig.
4F–H) were evaluated in the cells recruited in the pleural cavity
of rats injected with carrageenin that did or did not receive
indicaxanthin. Oral administration of indicaxanthin at 0.5, 1,
and 2 mmol/kg dose-dependently decreased all the carrageenin-
induced inflammatory parameters, with the exception of IL-1b
(Fig. 4B).
Indicaxanthin inhibits NF-kB activation in carrageenin-
induced rat pleurisy. The inflammatory response is under
control of several transcription factors, including NF-kB (33).
The mechanisms underlying the anti-inflammatory effects of
indicaxanthin were investigated by evaluating the effect of the
phytochemical on the activation state of NF-kB. The band of
NF-kB/DNA complex was evident 4 h after carrageenin injection,
peaked at 24 h, and then decreased but was still detectable 48 h
later (Fig. 5A). Oral administration of indicaxanthin (2 mmol/kg)
decreased the activation state of NF-kB at 4 and 24 h, with no
effect at 48 h (Fig. 5A). The effect at 24 h was dose-dependent in
the indicaxanthin range of 0.5–2.0 mmol/kg. (Fig. 5B).
Pharmacokinetics of indicaxanthin in rats. The pharmacoki-
netic profile of indicaxanthin was assessed by evaluating plasma
kinetics and urinary excretion of the pigment after a single oral
administration of 2 mmol/kg. The phytochemical was detectable
after 45 min, and a 0.2 mmol/L plasma peak concentration was
reached 2 h after ingestion (Fig. 6). The compound disappeared
from plasma after 4 h. Log transformation of the plasma
concentrations during the period 2–4 h after ingestion indicated
that the disposal of indicaxanthin followed first-order kinetics and
had a calculated half-life of 1.15 6 0.11 h. Urine samples were
collected over 12 h, and the total amount of indicaxanthin
excreted was 21 6 1.2% of the administered dose. Because
indicaxanthin is not metabolized at either the intestinal or liver
level (20,21), conjugation products were not measured in urine.
Discussion
Dietary phytochemicals are continuously investigated to under-
stand the basis of protective activity of fruits and vegetables
against chronic inflammation-based disorders and to discover
any nutraceutical potential of specific compounds. With this
study, to the best of our knowledge, the health-promoting effects
of indicaxanthin have been explored for the first time in vivo in
an animal model of acute inflammation. Our data show that this
betalain has a remarkable anti-inflammatory activity and thera-
peutic potential.
Food phytochemicals associated with health benefits include
glucosynolates, carotenoids, and phytosterols and a large number
of polyphenols. The latter, in particular, because of their chemistry,
have been considered ideal candidates to regulate and/or interfere
with the redox-dependent signaling processes underlying the
inflammatory response (1). However, a key issue to decide about
the real beneficial effects of dietary phytochemicals on human
health is their bioavailability, which must be referred not only to
the tested compounds but also to their metabolic products (23,34).
Anti-inflammatory activity and effects exhibited by plant
FIGURE 3 Release of proinflammatory mediators nitrite/nitrate (A),
PGE2 (B), TNF-a (C), and IL-1b (D) at 24 h in carrageenin-treated rats
administered 0–2 mmol/kg indicaxanthin. Values are means 6 SEMs,
n = 30 (10 rats in 3 separate experiments). Labeled means without a
common letter differ: P , 0.05.
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polyphenols in vitro are frequently diminished or even lost in
vivo because of incomplete absorption and first-pass metabolism
(23,35). In addition, some dietary phytochemicals reported to
modulate the inflammatory response are effective only when
intraperitoneally administered (36,37) or given orally at doses
too high to be of nutritional interest.
A number of studies from our and other laboratories showed
that 2 major dietary betalain pigments, such as betanin and
indicaxanthin, are bioavailable in humans from various food
sources (20,38,39) and are not modified to be absorbed (20,40).
Indicaxanthin, in particular, measured in human plasma after
consumption of dietary amounts of cactus pear fruit pulp,
reached a high micromolar peak at 3 h, with a clearance with
first-order kinetics in the following 5 h (20), and an excreted
amount representing ;70% of that ingested with food (20).
We demonstrate here that even pure indicaxanthin, given orally to
rats at amounts comparable with its intake with a reasonable
amount of food (20), is absorbed and is recovered unmodified in
plasma. There also is evidence that, at least in rats, the pure
molecule, even deprived of its food matrix, is resistant to the
gastrointestinal digestion process and is bioavailable. This is
in line with previous findings from simulated gastrointestinal
digestion showing that >70% of indicaxanthin, either from food
or as a pure compound, was recovered in the postintestinal
bioaccessible fraction (41), further indicating the remarkable
digestive stability of this molecule.
FIGURE 4 IL-1b, TNF-a, induc-
ible NO synthase (iNOS), and cy-
clooxygenase-2 (COX2) mRNA
expression (A–E) and iNOS and
COX-2 protein levels (F–H) in car-
rageenin-treated rats administered
0–2 mmol/kg indicaxanthin. Immu-
noblots are representative images
of three experiments with compa-
rable results. Values are means 6
SEMs, n = 30 (10 rats in 3 separate
experiments). Labeled means
without a common letter differ:
P , 0.05. COX2, cyclooxygenase-2;
iNOS, inducible NO synthase.
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Carrageenin causes a reproducible inflammatory reaction and
is considered a standard chemical for examining effects of anti-
inflammatory drugs (24,42). It has been used in animal models of
colon inflammation, but also of extracolonic sites, including
pleural space and peritoneum. In our carrageenin-induced rat
pleurisy, we observed that indicaxanthin, administered orally
30 min before the inflammatory insult and subsequently at 8 h
intervals, suppressed dose-dependently the onset of the acute
phase of the inflammatory response by decreasing both the
number of inflammatory cells recruited into the pleural cavity
and the volume of exudate at 24 h. An almost total prevention
(95%) of the acute response at 24 h was observed at the
highest amount (2 mmol/kg). This anti-inflammatory effect
was associated with a reduction of release into the pleural cavity
of a number of proinflammatory mediators, such as PGE2, and
oxidation products from nitrite, from the activity of COX and
iNOS, respectively, as well as the cytokines IL-1b and TNF-a.
Onset and progression of inflammatory response are complex
and dynamic processes involving pathophysiologic mechanisms
with sequential recruitment of different cell types and phenotyp-
ical and functional cell evolution, and a number of biochemical
reactions. In response to noxious stimuli, tissue-residentMPs start
the response with secretion of TNF-a and IL-1b, broad-spectrum
cytokines that stimulate neutrophils, fibroblasts, and endothelial
cells (32). The response of the latter mainly consists of recruiting
other immune cells to the site of inflammation, thus amplifying
and perpetuating the inflammatory reaction. In our carrageenin-
inflamed animal model, oral administration of indicaxanthin
caused a rapid decrease of IL-1b, TNF-a, iNOS, and COX2
mRNA in the leukocytes recruited in the pleural cavity at the
early phase of the inflammatory response, followed by the
inhibition of iNOS and COX-2 protein expression at the acute
phase, indicating an effect at the transcriptional level and possibly
suggesting intervention of themolecule on inflammatory pathways
driving the evolution of the inflammatory response. Our recent in
vitro studies demonstrate that indicaxanthin can elicit formation
of anti-inflammatory prostanoids, such as PGJ2 in cultured
rat MPs (M. Allegra, F. D#Acquisto, L. Tesoriere, A. Attanzio,
M. A. Livrea, unpublished data). The observed effects of
indicaxanthin were significantly greater on the cells at the
acute phase. However, our experimental design precludes
whether a specific cell, whether PMN or monocyte/MC, is
targeted by indicaxanthin because of the dynamic and continuous
cell transformation from one phenotype to another.
Distribution of absorbed dietary compounds in tissues or
cells is essential to their eventual activity. Our previous human
study showed that absorbed indicaxanthin can distribute within
red blood cells (20). The present findings show activity of the
molecule at the level of leukocytes recruited in the pleural cavity,
indicating that indicaxanthin can enter in other cells.
At a molecular level, the inflammatory activity of carrageenin
has been shown to go through activation of the pleiotropic NF-kB
(43), a key factor of the inflammatory cascade necessary to
activate transcription of proinflammatory genes. Consensus-
binding sequences for NF-kB have been identified in the promoter
regions of several genes implicated in the pathogenesis of acute
and chronic inflammation, such as TNF-a, IL-1b, COX2, and
iNOS, which makes NF-kB a main target for a number of
potential anti-inflammatory molecules (44) and its inhibition
a very promising weapon to fight inflammation-based disorders
FIGURE 5 NF-kB/DNA binding ac-
tivity in carrageenin-treated rats ad-
ministered 0–2 mmol/kg indicaxanthin.
Kinetic profile (A) and dose depen-
dency (B). Electrophoretic mobility-
shift assay image is representative of
three experiments with comparable
results. Values are means 6 SEMs,
n = 30 (10 rats in 3 separate experi-
ments). In A, asterisks indicate that
means at a time differ (by a Bonferroni
test): **P = 0.0022; in B, labeled
means without a common letter dif-
fer: P , 0.05; NS indicates P . 0.05.
FIGURE 6 Kinetics of plasma indicaxanthin in rats after ingestion of
2 mmol/kg. Values are means 6 SEMs, n = 15 (five rats in 3 separate
experiments). Labeled means without a common letter differ: P , 0.05.
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(45). In this context, the observation that anti-inflammatory
effects of indicaxanthin can be related, at least in part, to its
ability to reduce NF-kB activation appears of a great relevance
to consider its potential as health-promoting substance. In
conclusion, to the best of our knowledge, this study demonstrates
the remarkable pharmacologic effects exerted by indicaxanthin in
an in vivo model of the inflammatory condition and establishes for
the first time a health-promoting potential for indicaxanthin
administered orally at nutritionally relevant doses.
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